Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Esteban

Showing results (61-70 of 224) with videos related to

Pageof 23
Sort By:
Gastroenterologia Y Hepatologia|May 8, 2012
[Position paper of the Catalan Society of Gastroenterology: treatment of Genotype 1 Chronic Hepatitis C Virus with Triple Therapy]Miquel Bruguera, Rafael Esteban, Xavier Forns, et al.
Journal of Clinical Microbiology|December 5, 2008
Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapyRosendo Jardi, Francisco Rodriguez-Frias, David Tabernero, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 12, 2010
High doses of beta-blockers and alcohol abstinence improve long-term rebleeding and mortality in cirrhotic patients after an acute variceal bleedingLaura Muntaner, José Trinidad Altamirano, Salvador Augustin, et al.
Gastroenterologia Y Hepatologia|August 12, 2020
Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020)Manuel Rodríguez, María Buti, Rafael Esteban, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 31, 2005
Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessmentMontserrat Ferrer, Juan Córdoba, Olatz Garin, et al.
Current Medical Research and Opinion|October 26, 2016
Lercanidipine valuable effect on urine protein losses: the RED LEVEL studyNicolas Roberto Robles, Carlos Calvo, Javier Sobrino, et al.
European Journal of Gastroenterology & Hepatology|October 2, 2009
Quality of life in cirrhosis is related to potentially treatable factorsIñigo Les, Eduardo Doval, Montserrat Flavià, et al.
Journal of Hepatology|April 25, 2008
Thrombocytopenia associated with chronic liver diseaseNezam Afdhal, John McHutchison, Robert Brown, et al.
Journal of Hepatology|May 5, 2004
Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shuntsMaría Ortiz, Juan Córdoba, Juli Alonso, et al.
Journal of Hepatology|July 23, 2003
Quality of life and cognitive function in hepatitis C at different stages of liver diseaseJuan Córdoba, Montse Flavià, Carlos Jacas, et al.
Pageof 23

Showing results (61-70 of 224) with videos related to

Sort By:
Pageof 23
Gastroenterologia Y Hepatologia|May 8, 2012
[Position paper of the Catalan Society of Gastroenterology: treatment of Genotype 1 Chronic Hepatitis C Virus with Triple Therapy]Miquel Bruguera, Rafael Esteban, Xavier Forns, et al.
Journal of Clinical Microbiology|December 5, 2008
Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapyRosendo Jardi, Francisco Rodriguez-Frias, David Tabernero, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 12, 2010
High doses of beta-blockers and alcohol abstinence improve long-term rebleeding and mortality in cirrhotic patients after an acute variceal bleedingLaura Muntaner, José Trinidad Altamirano, Salvador Augustin, et al.
Gastroenterologia Y Hepatologia|August 12, 2020
Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020)Manuel Rodríguez, María Buti, Rafael Esteban, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 31, 2005
Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessmentMontserrat Ferrer, Juan Córdoba, Olatz Garin, et al.
Current Medical Research and Opinion|October 26, 2016
Lercanidipine valuable effect on urine protein losses: the RED LEVEL studyNicolas Roberto Robles, Carlos Calvo, Javier Sobrino, et al.
European Journal of Gastroenterology & Hepatology|October 2, 2009
Quality of life in cirrhosis is related to potentially treatable factorsIñigo Les, Eduardo Doval, Montserrat Flavià, et al.
Journal of Hepatology|April 25, 2008
Thrombocytopenia associated with chronic liver diseaseNezam Afdhal, John McHutchison, Robert Brown, et al.
Journal of Hepatology|May 5, 2004
Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shuntsMaría Ortiz, Juan Córdoba, Juli Alonso, et al.
Journal of Hepatology|July 23, 2003
Quality of life and cognitive function in hepatitis C at different stages of liver diseaseJuan Córdoba, Montse Flavià, Carlos Jacas, et al.
Pageof 23